4
Changes in Ownership
Kodiak Sciences Inc. Filed Acc 0001754045-26-000002
Chief Financial Officer sold 30,000 shares at an average $39.92 ($1,197,488)
- Chief Financial Officer acquired 30,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Option exercise 10b5-1 | +30,000 | $1.04 | $31,200 | 213,316 | D: show line 1 in the form |
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Sale 10b5-1 | −12,692 | $39.14 | $496,765 | 200,624 | D: show line 2 in the form |
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Sale 10b5-1 | −12,477 | $40.29 | $502,698 | 188,147 | D: show line 3 in the form |
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Sale 10b5-1 | −4,231 | $40.88 | $172,963 | 183,916 | D: show line 4 in the form |
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Sale 10b5-1 | −600 | $41.77 | $25,062 | 183,316 | D: show line 5 in the form |
| Open-market sales · 30,000 sh · avg $39.92 · $1,197,488 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. Chief Financial Officer | 2026-04-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 58,614 | D: show line 6 in the form |
Loading xslF345X06/form4-04032026_120417.xml…